Article
A novel AllGlo probe-quantitative PCR method for detecting single nucleotide polymorphism in CYP2C19 to evaluate the antiplatelet activity of clopidogrel.
Scientific reports - 29 Jan 2024
Li Hongwei, Fang Yizhen, Chen Yongquan, Lin Yuning, Fang Zanxi, Lin Zhiyuan, Xie Huabin, Zhang Zhongying
Abstract excerpt
CYP2C19 gene has multiple single nucleotide polymorphism (SNP), which is the major determinant for clopidogrel treatment responses. Therefore, CYP2C19 SNP detection is essential for predicting clopidogrel efficacy. Currently, there is still no quick and effective method for routine detection of common CYP2C19 SNPs in clinical laboratories, which is critically needed prior to clopidogrel treatment. AllGlo™ based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
